Water-soluble pristine C60 fullerene attenuates acetaminophen-induced liver injury

作者: Halyna Kuznietsova , Oksana Lynchak , Natalia Dziubenko , Tetyana Herheliuk , Yuriy Prylutskyy

DOI: 10.15171/BI.2019.28

关键词:

摘要: Introduction: Oxidative stress has been suggested as the main trigger and pathological mechanism of toxic liver injury. Effects powerful free radical scavenger С60 fullerene on rat injury cells (HepG2 line) were aimed to be discovered. Methods: Acute (ALI) was simulated by single acetaminophen (APAP, 1000 mg/kg) administration, a chronic CLI, 4 weekly APAP administrations. Pristine C60 aqueous colloid solution (C60FAS; initial concentration 0.15 mg/mL) administered per os or intraperitoneally at dose 0.5 mg/kg 0.25 (CLI) daily for 2 28 days, respectively, after first dose. Animals sacrificed 24th hour last Biochemical markers blood serum autopsies analyzed. EGFR expression in HepG2 48-hour incubation with C60FAS assessed. Results: Increase conjugated unconjugated bilirubin (up 1.4-3.7 times), ALT (by 31-37%), AST 18%) non-treated ALI CLI rats observed, suggesting hepatitis (confirmed histological analysis). Liver morphological state (ALI, CLI), (ALI (CLI), α-amylase, creatinine normalized administration both ways, which may indicate its protective impact liver. However, sharply increased animals receiving 12 times compared control), augmentation metabolism. Furthermore, inhibited dose-dependent manner. Conclusion: could partially correct acute injury, however, it not normalize metabolism exposure.

参考文章(68)
H. W. Kroto, J. R. Heath, S. C. O’Brien, R. F. Curl, R. E. Smalley, C 60 : Buckminsterfullerene Nature. ,vol. 318, pp. 162- 163 ,(1985) , 10.1038/318162A0
Muhammad Najam-ul-Haq, Rania Bakry, Rainer M Vallant, Christian W Huck, Zoltan Szabo, Matthias Rainer, Günther K Bonn, Medicinal applications of fullerenes. International Journal of Nanomedicine. ,vol. 2, pp. 639- 649 ,(2007)
Swan N. Thung, Arief A. Suriawinata, Liver Pathology: An Atlas and Concise Guide ,(2011)
Svitlana V Prylutska, Iryna I Grynyuk, Peter Scharff, Anatoliy P Burlaka, Uwe Ritter, Olga P Matyshevska, Alexandr A Golub, Yuriy I Prylutskyy, Therapeutic reactive oxygen generation Tumori. ,vol. 94, pp. 278- 283 ,(2008) , 10.1700/346.4049
Jagannath Padmanabhan, Themis R. Kyriakides, Nanomaterials, Inflammation, and Tissue Engineering Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology. ,vol. 7, pp. 355- 370 ,(2015) , 10.1002/WNAN.1320
Farnaz Farsi, Majid Mohammadshahi, Pezhman Alavinejad, Afshin Rezazadeh, Mehdi Zarei, Kambiz Ahmadi Engali, Functions of Coenzyme Q10 Supplementation on Liver Enzymes, Markers of Systemic Inflammation, and Adipokines in Patients Affected by Nonalcoholic Fatty Liver Disease: A Double-Blind, Placebo-Controlled, Randomized Clinical Trial. Journal of The American College of Nutrition. ,vol. 35, pp. 346- 353 ,(2016) , 10.1080/07315724.2015.1021057
Simin Zhang, Hongqiu Pan, Xianzhen Peng, Hui Lu, Hong Fan, Xianzhi Zheng, Guisheng Xu, Min Wang, Jianming Wang, Preventive use of a hepatoprotectant against anti‐tuberculosis drug‐induced liver injury: A randomized controlled trial Journal of Gastroenterology and Hepatology. ,vol. 31, pp. 409- 416 ,(2016) , 10.1111/JGH.13070
Gui-Qi Zhu, Ke-Qing Shi, Gui-Qian Huang, Li-Ren Wang, Yi-Qian Lin, Martin Braddock, Yong-Ping Chen, Meng-Tao Zhou, Ming-Hua Zheng, A network meta-analysis of the efficacy and side effects of UDCA-based therapies for primary sclerosing cholangitis. Oncotarget. ,vol. 6, pp. 26757- 26769 ,(2015) , 10.18632/ONCOTARGET.5610
P. J. KRUSIC, E. WASSERMAN, P. N. KEIZER, J. R. MORTON, K. F. PRESTON, Radical reactions of c60. Science. ,vol. 254, pp. 1183- 1185 ,(1991) , 10.1126/SCIENCE.254.5035.1183
C. Schuetze, U. Ritter, P. Scharff, U. Fernekorn, S. Prylutska, A. Bychko, V. Rybalchenko, Yu. Prylutskyy, Interaction of N-fluorescein-5-isothiocyanate pyrrolidine-C60 with a bimolecular lipid model membrane Materials Science and Engineering: C. ,vol. 31, pp. 1148- 1150 ,(2011) , 10.1016/J.MSEC.2011.02.026